Stockscreener 앱 받기
4.54
2.05%
-0.095
시간 외 거래:
4.61
0.07
+1.54%
전일 마감가:
$4.635
열려 있는:
$4.54
하루 거래량:
4,012
Relative Volume:
0.14
시가총액:
$8.71M
수익:
$7.70M
순이익/손실:
$-33.38M
주가수익비율:
-0.3687
EPS:
-12.3134
순현금흐름:
$-39.92M
1주 성능:
+12.10%
1개월 성능:
-11.50%
6개월 성능:
-13.19%
1년 성능:
-45.29%
1일 변동 폭
$4.54
$4.65
1주일 범위
$3.91
$4.6799
52주 변동 폭
$3.91
$9.66
볼트 바이오테라퓨틱스 Stock (BOLT) Company Profile
명칭
Bolt Biotherapeutics Inc
전화
650-665-9295
주소
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
4.54 | 8.90M | 7.70M | -33.38M | -39.92M | -12.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
볼트 바이오테라퓨틱스 Stock (BOLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 재개 | H.C. Wainwright | Buy |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | 개시 | Guggenheim | Buy |
| 2021-03-02 | 개시 | Morgan Stanley | Overweight |
| 2021-03-02 | 개시 | SVB Leerink | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
볼트 바이오테라퓨틱스 주식(BOLT)의 최신 뉴스
Weekly Earnings: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Fundamentals Check: Does Bolt Biotherapeutics Inc have strong EBITDA margins2026 Bull vs Bear & Community Consensus Trade Signals - baoquankhu1.vn
Whats the outlook for Bolt Biotherapeutics Incs sector2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn
Market Outlook: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
HC Wainwright Reiterates Buy Rating for Bolt Biotherapeutics (BO - GuruFocus
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - theheraldreview.com
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - Bitget
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Bolt Biotherapeutics Inc.: Fourth Quarter Financial Results Overview - Bitget
BOLT Reports Q4 Revenue Surpassing Expectations - GuruFocus
Bolt Biotherapeutics 10-K: $7.7M Revenue, $(17.85) EPS - TradingView
Bolt Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cost cuts help Bolt Biotherapeutics (NASDAQ: BOLT) halve 2025 loss - Stock Titan
Bolt tests new gastric cancer drug, $31.8M cash into 2027 - Stock Titan
Take Profit: Is Bolt Biotherapeutics Inc a speculative investmentMarket Volume Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Can Bolt Biotherapeutics Inc. stock maintain growth trajectoryEarnings Recap Report & Real-Time Market Trend Scan - Naître et grandir
Is Bolt Biotherapeutics Inc. (6LP0) stock overpriced at current multiplesDividend Hike & Step-by-Step Swing Trade Plans - Naître et grandir
BOLTBolt Biotherapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Is Bolt Biotherapeutics Inc likely to announce a buybackJuly 2025 Technicals & Reliable Trade Execution Plans - baoquankhu1.vn
BOLT SEC FilingsBolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Portfolio Update: Will Bolt Biotherapeutics Inc announce a stock splitJuly 2025 Selloffs & Reliable Intraday Trade Alerts - baoquankhu1.vn
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Bolt Biotherapeutics to Participate in Upcoming March Conferences - Bitget
Ideas Watch: Is Bolt Biotherapeutics Inc a speculative investmentProduct Launch & Technical Pattern Alert System - baoquankhu1.vn
Cancer drug developer Bolt Bio lines up two March investor events - Stock Titan
BOLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Layoff Tracker: Concerto Downsizes Amid Pivot to Consumer; Faraday Closes Down - BioSpace
Recap Report: Is TIM SA Depositary Receipt stock a hidden gemWeekly Profit Summary & Growth Focused Stock Pick Reports - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. impacted by rising ratesIndex Update & Weekly Setup with ROI Potential - mfd.ru
Is Bolt Biotherapeutics Inc. likely to announce a buybackRecession Risk & Smart Money Movement Alerts - mfd.ru
Why Bolt Biotherapeutics Inc. (6LP0) stock stays undervaluedTrade Signal Summary & Community Supported Trade Ideas - mfd.ru
Is Bolt Biotherapeutics Inc. stock forming a cup and handleJuly 2025 Earnings & Intraday High Probability Setup Alerts - mfd.ru
Is Bolt Biotherapeutics Inc. a speculative investmentJuly 2025 WrapUp & Daily Profit Focused Screening - mfd.ru
H.C. Wainwright Raises Protagonist Therapeutics, Inc. (PTGX) Target to $117, Reiterates Buy - Finviz
Treasury Yields: Is Bolt Biotherapeutics Inc. a top pick in the sectorPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Radiopharm Theranostics (NASDAQ:RADX) versus Bolt Biotherapeutics (NASDAQ:BOLT) Head-To-Head Survey - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Bolt Biotherapeutics (NASDAQ:BOLT) Stock Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Growth Review: What are the analyst revisions for Bolt Biotherapeutics Inc.Is ZKIN stock a good investment in YEARDollar Strength & Low Risk High Reward Ideas - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. still a buy after recent gains2025 Momentum Check & Free High Accuracy Swing Entry Alerts - mfd.ru
Insider Trends: What is the long term forecast for Bolt Biotherapeutics Inc stockJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Risk Recap: Can ETRACS 2x Leveraged US Value Factor TR ETN maintain sales growth2025 Trade Ideas & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Nasdaq Moves: Whats the outlook for Bolt Biotherapeutics Incs sector2025 Valuation Update & Technical Confirmation Trade Alerts - baoquankhu1.vn
Bolt (Fastener) Market Covering Prime Factors and Competitive - openPR.com
Risks Report: What are the analyst revisions for Bolt Biotherapeutics IncIs ZKIN stock a good investment in YEARMarket Growth Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Is Bolt Biotherapeutics Inc a top pick in the sectorJuly 2025 Chart Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Weekly Recap: Can Quince Therapeutics Inc sustain its profitabilityJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Portfolio Shifts: Is Bolt Biotherapeutics Inc a top pick in the sectorJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
Aug Final Week: Does ELAB stock reflect fundamentalsBull Run & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Bolt appoints Olta Andoni as SVP of legal and people to support platform expansion across checkout, identity, and payments - marketscreener.com
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Short Interest Down 83.8% in December - Defense World
볼트 바이오테라퓨틱스 (BOLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):